1967
DOI: 10.1159/000466494
|View full text |Cite
|
Sign up to set email alerts
|

Hemagglutination by Human Anti-Leukocyte Serums

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
16
0

Year Published

1969
1969
2007
2007

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 8 publications
1
16
0
Order By: Relevance
“…In 1967 Rosenfield et al [24] described the existence of leukocyte antigens 5 b on the red cells in humans. This was later confirmed by Lalezahi [14].…”
Section: Discussionmentioning
confidence: 99%
“…In 1967 Rosenfield et al [24] described the existence of leukocyte antigens 5 b on the red cells in humans. This was later confirmed by Lalezahi [14].…”
Section: Discussionmentioning
confidence: 99%
“…Although lymphocytes will absorb the haemagglutinating antibody it has not been possible to determine whether the red cells will absorb the antibody reacting with lymphocytes. Rosenfield et al [10] reported that 4 absorptions of the anti-5b serum with red cells only reduced the antibody titre by 25% and suggested that this was due to the presence of extremely few antigenic sites on the red cells. Harris and Zerwas [6] claim that some of the HL-A antigens are present on reticulocytes and have disappeared from mature red cells.…”
Section: Discussionmentioning
confidence: 99%
“…Clarkson and Gorer [3] found an incomplete haemagglutinin in the serum of a patient who had received a skin graft which did not correspond to any red cell group. The use of the Auto Analyser enabled Rosenfield, Rubenstein, Lalezari, Dausset and van Rood [10] to find haemagglutinins in all of 26 human sera containing leucocyte antibodies. However, in only 2 sera of type anti-5b was the haemagglutinin of the same specificity as the white cell antibody.…”
mentioning
confidence: 99%
“…Blood units for transfusional use in recipients having developed such antibodies should therefore be selected by AA compatibility testing. In some cases, as noted by several authors [6,9], these sera may contain anti-Bg or other cross-reacting antibodies of the HL-A system. According to some early observations, we feel that at least part of these antibodies do not seem to have great clinical importance.…”
mentioning
confidence: 92%